Free Trial
→ Your Bank Account Is No Longer Safe (From Priority Gold) (Ad)
OTCMKTS:EDTXF

Spectral Diagnostics 8/9/2024 Earnings Report

Spectral Diagnostics logo
$0.61 0.00 (0.00%)
As of 06/20/2025
ProfileEarnings History

Spectral Diagnostics EPS Results

Actual EPS
-$0.01
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Spectral Diagnostics Revenue Results

Actual Revenue
$0.34 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Spectral Diagnostics Announcement Details

Quarter
Date
8/9/2024
Time
N/A
Conference Call Date
N/A
Conference Call Time
N/A

Upcoming Earnings

Spectral Diagnostics' next earnings date is estimated for Thursday, August 7, 2025, based on past reporting schedules.

Conference Call Resources

Spectral Diagnostics Earnings Headlines

Spectral Medical Inc. Announces Results of Annual Meeting of Shareholders
June 6, 2025 | globenewswire.com
Spectral Medical to Present at the 3rd Annual H.C. Wainwright BioConnect Investor Conference
May 16, 2025 | globenewswire.com
Your Bank Account Is No Longer Safe
What If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what the Department of Justice just admitted in court—claiming cash isn't legally your property. What does that mean? It means Washington thinks they can seize, freeze, or drain your accounts—whenever they want.
June 23, 2025 | Priority Gold (Ad)
Spectral Medical Announces First Quarter and Provides Corporate Update
May 9, 2025 | globenewswire.com
Spectral Medical Announces Non-Dilutive Financing of Up to $10 Million with Vantive
May 7, 2025 | globenewswire.com
Spectral Medical Inc.: Spectral Medical Completes Tigris Trial Enrollment
April 16, 2025 | finanznachrichten.de
See More Spectral Diagnostics Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Spectral Diagnostics? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Spectral Diagnostics and other key companies, straight to your email.

About Spectral Diagnostics

Spectral Medical Inc. focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, and internationally. The company markets Endotoxin Activity Assay, a rapid in vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream. It also develops and manufactures monoclonal and polyclonal antibodies, recombinant cardiac proteins, and calibrators for use in the research and development, as well as products that are manufactured by other diagnostic companies. The company was formerly known as Spectral Diagnostics (OTCMKTS:EDTXF) and changed its name to Spectral Medical Inc. in December 2014. Spectral Medical Inc. was incorporated in 1991 and is headquartered in Toronto, Canada.

View Spectral Diagnostics Profile

More Earnings Resources from MarketBeat

Earnings Tools
Earnings By Country
Latest Articles